Drugs / GSK1557482A
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00778895 | Nov 2008 → Aug 2009 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00980005 | Oct 2009 → Mar 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK1557482A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00980005 ↗ |
| Modality | Vaccine | “GSK Biologicals' investigational vaccine GSK1557482A” NCT00980005 ↗ |